Michael Knaggs has become head of computational chemistry at Sygnature Chemical Services, a Nottingham, UK-based provider of premium discovery chemistry services to the pharmaceutical industry.
Knaggs has more than 10 years" computational chemistry experience in the pharmaceutical industry and academia in the UK and US. He has been involved in virtual screening projects (structure-based and ligand-based approaches) in a variety of targets (CNS, tropical diseases, antivirals, antibacterials), pharmacophore modelling, QSAR and library design, as well as protein modelling and simulation work.
